Mechanistic examination of walnuts in prevention of breast cancer

Nutrition and Cancer

Volumn 64, Issue 7, 2012, Pages 1078-1086

  Heuvel, John P Vanden ^a   Belda, Benjamin J ^a   Hannon, Dan B ^a   Kris Etherton, Penny M ^a   Grieger, Jessica A ^a   Zhang, Jun ^a   Thompson, Jerry T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FARNESOID X RECEPTOR; LINOLENIC ACID; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SITOSTEROL;

ARTICLE; BODY MASS; BREAST CANCER; CANCER PREVENTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; GENE EXPRESSION; HUMAN; IN VITRO STUDY; WALNUT;

3T3 CELLS; ALPHA-LINOLENIC ACID; ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMOPREVENTION; EPITHELIAL CELLS; FEMALE; HUMANS; JUGLANS; MCF-7 CELLS; MICE; NUTS; ORPHAN NUCLEAR RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLANT EXTRACTS; PLANT OILS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SITOSTEROLS;

EID: 84867781731     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.717679     Document Type: Article

References (45)

1. Thiébaut, A C, Chajès, V, Gerber, M, Boutron-Ruault, M C, Joulin, V. 2009. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer, 124: 924-931.
2. Berquin, I M, Edwards, I J, and, Chen, Y Q. 2008. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett, 269: 363-377.
3. Comba, A, Maestri, D M, Berra, M A, Garcia, C P, Das, U N. 2010. Effect of -3 and -9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model. Lipids Health Dis, 9: 112
4. Ros, E. 2009. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr, 89: 1649S-1656S.
5. Gebauer, S K, Psota, T L, Harris, W S, and, Kris-Etherton, P M. 2006. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr, 83: 1526S-1535S.
6. Griel, A E, and, Kris-Etherton, P M. 2006. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr, 96 (Suppl 2): S68-S78.
7. McKay, D L, Chen, C Y, Yeum, K J, Matthan, N R, Lichtenstein, A H. 2010. Chronic and acute effects of walnuts on antioxidant capacity and nutritional status in humans: a randomized, cross-over pilot study. Nutr J, 9: 21
8. Maguire, L S, OSullivan, S M, Galvin, K, OConnor, T P, and, OBrien, N M. 2004. Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr, 55: 171-178.
9. Hardman, W E, and, Ion, G. 2008. Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer, 60: 666-674.
10. Carvalho, M, Ferreira, P J, Mendes, V S, Silva, R, Pereira, J A. 2010. Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food Chem Toxicol, 48: 441-447.
11. Aithal, B K, Kumar, M R, Rao, B N, Udupa, N, and, Rao, B S. 2009. Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells. Cell Biol Int, 33: 1039-1049.
12. Kim, J Y, Park, H D, Park, E, Chon, J W, and, Park, Y K. 2009. Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells. Ann NY Acad Sci, 1171: 190-195.
13. Comitato, R, Leoni, G, Canali, R, Ambra, R, Nesaretnam, K. 2010. Tocotrienols activity in MCF-7 breast cancer cells: involvement of ERbeta signal transduction. Mol Nutr Food Res, 54: 669-678.
14. Lee, H J, Ju, J, Paul, S, So, J Y, DeCastro, A. 2009. Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma. Clin Cancer Res, 15: 4242-4249.
15. Murff, H J, Shu, X O, Li, H, Yang, G, Wu, X. 2010. Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: A prospective cohort study. Int J Cancer, 128: 1434-1441.
16. Shannon, J, King, I B, Lampe, J W, Gao, D L, Ray, R M. 2009. Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China. Am J Clin Nutr, 89: 265-276.
17. Spaccarotella, K J, Kris-Etherton, P M, Stone, W L, Bagshaw, D M, Fishell, V K. 2008. The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J, 7: 13
18. Meyer, M D, and, Terry, L A. 2008. Development of a rapid method for the sequential extraction and subsequent quantification of fatty acids and sugars from avocado mesocarp tissue. J Agric Food Chem, 56: 7439-7445.
19. Vanden Heuvel, J P. 2009. Cardiovascular disease-related genes and regulation by diet. Curr Atheroscler Rep, 11: 448-455.
20. Zhao, G, Etherton, T D, Martin, K R, West, S G, Gillies, P J. 2004. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr, 134: 2991-2997.
21. Zhao, G, Etherton, T D, Martin, K R, Vanden Heuvel, J P, Gillies, P J. 2005. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun, 336: 909-917.
22. Zhao, G, Etherton, T D, Martin, K R, Gillies, P J, West, S G. 2007. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr, 85: 385-391.
23. Jardé, T, Caldefie-Chézet, F, Goncalves-Mendes, N, Mishellany, F, Buechler, C. 2009. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer, 16: 1197-1210.
24. Jardé, T, Perrier, S, Vasson, M P, and, Caldefie-Chézet, F. 2011. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer, 47: 33-43.
25. Lautenbach, A, Budde, A, Wrann, C D, Teichmann, B, Vieten, G. 2009. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer, 61: 484-491.
26. Grossmann, M E, Nkhata, K J, Mizuno, N K, Ray, A, and, Cleary, M P. 2008. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer, 98: 370-379.
27. Dieudonne, M N, Machinal-Quelin, F, Serazin-Leroy, V, Leneveu, M C, Pecquery, R. 2002. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 293: 622-628.
28. Weichhaus, M, Broom, I, and, Bermano, G. 2011. The molecular contribution of TNF- in the link between obesity and breast cancer. Oncol Rep, 25: 477-483.
29. Jenkins, D J, Kendall, C W, Vidgen, E, Agarwal, S, Rao, A V. 1999. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr, 69: 395-402.
30. Singhal, R, Badger, T M, and, Ronis, M J. 2007. Reduction in 7,12-dimethylbenz[a]anthracene-induced hepatic cytochrome-P450 1A1 expression following soy consumption in female rats is mediated by degradation of the aryl hydrocarbon receptor. J Nutr, 137: 19-24.
31. Henning, S M, Aronson, W, Niu, Y, Conde, F, Lee, N H. 2006. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr, 136: 1839-1843.
32. Iyengar, P, Combs, T P, Shah, S J, Gouon-Evans, V, Pollard, J W. 2003. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene, 22: 6408-6423.
33. Bougnoux, P, Maillard, V, Ferrari, P, and, Jourdan, M L. 2002. V. Chajès, n-3 fatty acids and breast cancer. IARC Sci Publ, 156: 337-341.
34. Park, C, Moon, D O, Ryu, C H, Choi, B, Lee, W. 2008. Beta-sitosterol sensitizes MDA-MB-231 cells to TRAIL-induced apoptosis. Acta Pharmacol Sin, 29: 341-348.
35. Awad, A B, Downie, A, Fink, C S, and, Kim, U. 2000. Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res, 20: 821-824.
36. Awad, A B, Chinnam, M, Fink, C S, and, Bradford, P G. 2007. beta-Sitosterol activates Fas signaling in human breast cancer cells. Phytomedicine, 14: 747-754.
37. Awad, A B, Roy, R, and, Fink, C S. 2003. Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. Oncol Rep, 10: 497-500.
38. Awad, A B, and, Fink, C S. 2000. Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr, 130: 2127-2130.
39. Shay, N F, and, Banz, W J. 2005. Regulation of gene transcription by botanicals: novel regulatory mechanisms. Annu Rev Nutr, 25: 297-315.
40. Vanden Heuvel, J P, Thompson, J T, Frame, S R, and, Gillies, P J. 2006. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci, 92: 476-489.
41. Swales, K E, Korbonits, M, Carpenter, R, Walsh, D T, Warner, T D. 2006. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Cancer Res, 66: 10120-10126.
42. Catalano, S, Malivindi, R, Giordano, C, Gu, G, Panza, S. 2010. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells. J Biol Chem, 285: 5581-5593.
43. Journe, F, Durbecq, V, Chaboteaux, C, Rouas, G, Laurent, G. 2009. Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients. Breast Cancer Res Treat, 115: 523-535.
44. West SC, Krick AL, Klein LC, Zhao G, Wojtowicz TF, et al. 2010. Effects of diet high in walnuts and flax oil on hemodynamic responses to stress and vascular endothelial function. J Am Coll Nutr., 29: 595-603.
45. Marzolini, C, Tirona, R G, Gervasini, G, Poonkuzhali, B, Assem, M. 2007. A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. Mol Endocrinol, 21: 1769-1780.